gms | German Medical Science

60. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit den Benelux-Ländern und Bulgarien

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

24. - 27.05.2009, Münster

Vorträge Dienstag, 26. Mai 2009
DI.03 Subarachnoid hemorrhage II

Meeting Abstract (DI.03-01)

Effects and mechanisms of Erythropietin on experimental vasospasm in the rat double haemorrhage model

Vatter H, Güresir E, Raab P, Vasiliadis N, Raabe A, Seifert V
Meeting Abstract (DI.03-02)

High-dose recombinant erythropoietin treatment after experimental SAH in rats: pharmacokinetics and clinical assessment

Güresir E, Raabe A, Vasiliadis N, Dias S, Seifert V, Vatter H
Meeting Abstract (DI.03-03)

Reduced vasospasm in S100A9 knock-out mice after experimental SAH

Fischer B, Penz O, Hüsken H, Nacken W, Wassmann H
Meeting Abstract (DI.03-04)

Dose-related efficacy of a continuous intracisternal nimodipine treatment on cerebral vasospasm in the rat double subarachnoid haemorrhage model

Hänggi D, Eicker S, Beseoglu K, Rapp M, Perrin J, Steiger HJ
Meeting Abstract (DI.03-05)

Preliminary results with nanoparticles for experimental aneurysm embolisation

Reinges M, Kirkpatrick P, Spiegelberg A, Krings T, Hans FJ
Meeting Abstract (DI.03-06)

Free caspase activity – a prognostic indicator in patients suffering from subarachnoid haemorrhage?

Heiroth HJ, Höllerich J, Albrecht P, Methner A, Steiger HJ, Hänggi D
Meeting Abstract (DI.03-07)

Cerebral Interleukin-6 in aneurysmal subarachnoid haemorrhage (aSAH) patients

Graetz D, Nagel A, Gericke C, Vajkoczy P, Sarrafzadeh A
Meeting Abstract (DI.03-08)

Correlation of aneurysm-related and epidemiological factors after SAH: results from a large cohort analysis

Etminan N, Beseoglu K, Turowski B, Steiger HJ, Hänggi D
Meeting Abstract (DI.03-09)

Lower incidence of vasospasm after aneurysmal subarachnoid haemorrhage in the elderly patient? A prospective clinical series

Wachter D, Rohde V